Kringle Pharma
4884.TPharmaceutical
Filed as Kringle Pharma, Inc. (2022-08–2026-05), Kringle Pharma, Inc (2023-05–2023-05)
Financials · Standalone
| Fiscal year ended | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 | 2020-09 |
|---|---|---|---|---|---|---|
| Revenue | ¥72m | ¥80m | ¥69m | ¥392m | ¥290m | ¥468m |
| Operating income | −¥909m | −¥818m | −¥889m | −¥426m | −¥358m | — |
| Ordinary income | −¥915m | −¥755m | −¥853m | −¥330m | −¥300m | −¥116m |
| Total assets | ¥2.1bn | ¥2.8bn | ¥2.6bn | ¥3.2bn | ¥2.6bn | ¥2.4bn |
| Net assets / equity | ¥1.3bn | ¥2.1bn | ¥2.0bn | ¥2.8bn | ¥2.5bn | ¥2.2bn |
| Operating cash flow | −¥756m | −¥661m | −¥689m | ¥16m | −¥561m | −¥146m |
| EPS (basic) | ¥-133.92 | ¥-118.21 | ¥-158.46 | ¥-68.33 | ¥-72.51 | ¥-106.7 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 12
| Period | Form | Figures |
|---|---|---|
| 2025-10-01 → 2026-03-31 | Half-year | 66 figures · EDINET |
| 2024-10-01 → 2025-09-30 | Annual | 106 figures · EDINET |
| 2024-10-01 → 2025-03-31 | Half-year | 66 figures · EDINET |
| 2023-10-01 → 2024-09-30 | Annual | 105 figures · EDINET |
| 2023-10-01 → 2024-03-31 | Quarterly Q2 | 68 figures · EDINET |
| 2023-10-01 → 2023-12-31 | Quarterly Q1 | 42 figures · EDINET |
| 2022-10-01 → 2023-09-30 | Annual | 102 figures · EDINET |
| 2022-10-01 → 2023-06-30 | Quarterly Q3 | 44 figures · EDINET |
| 2022-10-01 → 2023-03-31 | Quarterly Q2 | 68 figures · EDINET |
| 2022-10-01 → 2022-12-31 | Quarterly Q1 | 42 figures · EDINET |
| 2021-10-01 → 2022-09-30 | Annual | 100 figures · EDINET |
| 2021-10-01 → 2022-06-30 | Quarterly Q3 | 44 figures · EDINET |
7 more reports are still being processed.